A Study of Tabalumab (LY2127399) in Participants With Previously Treated Multiple Myeloma (MM)
Status:
Completed
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate an investigational drug called tabalumab in
participants with Multiple Myeloma (MM) who have tried at least one other therapy in the
past. Tabalumab will be given in combination with standard doses of two other drugs that are
often used to treat MM. Study doctors will collect information about the effectiveness and
side effects of this therapy.